https://www.marketscreener.com/quote/stock/ASTELLAS-PHARMA-INC-6491262/news/Astellas-Pharma-Inc-Discontinues-Development-of-Darexaban-YM150-an-Oral-Direct-Factor-Xa-Inhibi-13815135/?utm_source=telegram&utm_medium=social&utm_campaign=share